Dr. Richard Dalby steps down as associate dean for academic affairs; former chair of the Department of Pharmaceutical Sciences named as successor.

Presentations delivered by leaders across academia and industry highlight new methods and approaches to drug design that attendees can apply in their laboratories.

Day-long learning session and health fair educated members of the local community about ongoing projects in the field of patient-centered outcomes research (PCOR).

More than 200 PharmD and graduate students receive degrees and embark on the next phase of their lives.

Fellowships will provide students with the hands-on experience and leadership skills needed to pursue careers in clinical drug development.

Research Day offers an opportunity for students and trainees to showcase their current research and network with potential collaborators.

Researchers across academia, government, and industry explore how real world evidence can be harnessed to create a national evaluation system and improve the safety and effectiveness of medical devices.

Keynote speaker Dr. Freda Lewis-Hall addresses the importance of engaging patients as partners in health care and research to better understand their needs and the outcomes most important to them.

FDA praises the Center’s efforts to bring academic, government, and industry stakeholders together for collaborative project with wide-reaching implications.